Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

02 déc. 2025 09h00 HE | Source: ADARx Pharmaceuticals

ADARx Pharmaceuticals Appoints Mary Tagliaferri, M.D., to its Board of Directors

ADARx Pharmaceuticals Appoints Mary Tagliaferri, M.D., to its Board of Directors
20 oct. 2025 09h00 HE | Source: ADARx Pharmaceuticals

ADARx Pharmaceuticals Announces Clinical Data Presentation at the American Society of Nephrology (ASN) Kidney Week 2025

SAN DIEGO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA therapeutics, announced today that it...
04 sept. 2025 16h28 HE | Source: ADARx Pharmaceuticals

ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
10 janv. 2025 09h00 HE | Source: ADARx Pharmaceuticals

ADARx Pharmaceuticals to Present at the J.P. Morgan 43ʳᵈ Annual Healthcare Conference

ADARx to present at the JP Morgan Healthcare Conference
30 juil. 2024 09h05 HE | Source: ADARx Pharmaceuticals

ADARx Pharmaceuticals Appoints Ajim Tamboli, CFA as Chief Financial Officer

ADARx Pharmaceuticals Appoints Ajim Tamboli, CFA as Chief Financial Officer
02 avr. 2024 09h05 HE | Source: ADARx Pharmaceuticals

ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer

ADARx Pharmaceuticals, next-generation RNA therapeutics developer, appoints Dr. Chris Storgard as Chief Medical Officer